Article
Classic Ketogenic Diet and Modified Atkins Diet in SLC2A1 Positive and Negative Patients with Suspected GLUT1 Deficiency Syndrome: A Single Center Analysis of 18 Cases.
Nutrients - 4 Mar 2021
Ruiz Herrero Jana, Cañedo Villarroya Elvira, González Gutiérrez-Solana Luis, García Alcolea Beatriz, Gómez Fernández Begoña, Puerta Macfarland Laura Andrea, Pedrón-Giner Consuelo
Abstract excerpt
BACKGROUND: Glucose transporter type 1 deficiency syndrome (GLUT1DS) is caused by mutations in the SLC2A1 gene and produces seizures, neurodevelopmental impairment, and movement disorders. Ketogenic dietary therapies (KDT) are the gold standard treatment. Similar symptoms may appear in SLC2A1 negative patients. The purpose is to evaluate the effectiveness of KDT in children with GLUT1DS suspected SLC2A1 (+) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
